Related Experiment Video
Updated: Apr 15, 2026
09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
14.1K
Fulminant hepatic failure secondary to primary hepatic angiosarcoma
Ayokunle T Abegunde1, Efe Aisien2, Benjamin Mba2
1Department of Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IL 60612, USA ; Department of Medicine, Section of Digestive Diseases and Nutrition, Oklahoma University Health Sciences Center, Oklahoma City, OK 73104, USA.
Case Reports in Gastrointestinal Medicine
|March 28, 2015
Summary
This case report highlights a rare hepatic angiosarcoma (a fast-growing liver cancer) that rapidly progressed to fatal liver failure. Early detection and novel therapies are crucial for improving outcomes in this aggressive malignancy.
Area of Science:
- Oncology
- Hepatology
- Pathology
Background:
- Hepatic angiosarcoma is a rare, aggressive liver malignancy.
- It often presents late with vague symptoms and normal liver function initially.
- This tumor has a poor prognosis due to late diagnosis and limited treatment options.
Purpose of the Study:
- To present a case of primary hepatic angiosarcoma.
- To highlight the rapid progression of the disease.
- To review the literature on this rare malignancy.
Main Methods:
- Case report of a patient with hepatic angiosarcoma.
- Review of existing medical literature.
Main Results:
- A previously healthy man developed jaundice and rapidly progressed to fulminant hepatic failure.
- The patient was diagnosed with primary hepatic angiosarcoma.
- The case demonstrates the swift and fatal course of the disease.
Conclusions:
- Hepatic angiosarcoma can progress rapidly, leading to death shortly after symptom onset.
- There is a critical need for improved early diagnostic methods.
- Further research into novel therapies is essential to enhance prognosis for this rare cancer.
